Prana raises US$3.7 million
Wednesday, 08 December, 2004
A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.
The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.
The exercise of options increases the total issued shares in Prana to 126,890,821.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
